Next Article in Journal
Exploring Single-Nucleotide Polymorphisms in Primary and Secondary Male Infertility
Previous Article in Journal
The Novel Achievements in Oncological Metabolic Radio-Therapy: Isotope Technologies, Targeted Theranostics, Translational Oncology Research
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
This is an early access version, the complete PDF, HTML, and XML versions will be available soon.
Article

Are Calculated Immune Markers with or Without Comorbidities Good Predictors of Colorectal Cancer Survival? The Results of a Longitudinal Study

1
Division of Oncology, Department of Internal Medicine and Oncology, Semmelweis University, 1082 Budapest, Hungary
2
Department of Internal Medicine and Hematology, Semmelweis University, 1088 Budapest, Hungary
3
Department of Medical Oncology, Semmelweis University, 1122 Budapest, Hungary
4
National Institute of Oncology, 1122 Budapest, Hungary
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Med. Sci. 2025, 13(3), 108; https://doi.org/10.3390/medsci13030108 (registering DOI)
Submission received: 21 June 2025 / Revised: 17 July 2025 / Accepted: 31 July 2025 / Published: 1 August 2025
(This article belongs to the Section Cancer and Cancer-Related Research)

Abstract

Background/Objectives: Although numerous prognostic biomarkers have been proposed for colorectal cancer (CRC), their longitudinal evaluation remains limited. The aim of this study was to investigate longitudinal changes in biomarkers calculated from routinely used laboratory markers and their relationships to common chronic diseases (comorbidities). Methods: A retrospective longitudinal observational study was completed with the inclusion of 817 CRC patients and a total of 4542 measurement points. Pan-immune inflammation value (PIV), prognostic nutritional index (PNI), and systemic immune-inflammation index (SII) were calculated based on complete blood count and albumin measurement data. Results: Longitudinal data analyses confirmed the different values and slopes of the parameters tested at the different endpoints. Survivors had the lowest and most constant PIVs and SII values, and the highest and most slowly decreasing PNI values. Those patients with non-cancerous death had similar values to the previous cohort, but an increase/decrease occurred towards the death event. Patients with CRC-related death had significantly higher PIVs and SII values and significantly lower PNI values (p < 0.0001), and a significant increase/decrease was observed at the early observational periods. The presence of lymph node and/or distant metastases, adjuvant chemotherapy, and hypertension significantly affected PIVs and SII and/or PNI values. The changes in PIVs and SII and PNI values toward pathological values are poor prognostic signs (p < 0.0001). Conclusions: Each of the three calculated markers demonstrates suitability for longitudinal patient follow-up, and their pathological alterations over time serve as valuable prognostic indicators. They may also be useful to detect certain clinicopathological parameters early.
Keywords: colorectal neoplasms; longitudinal analysis; pan-immune inflammation value; prognostic nutritional index; systemic immune-inflammation index colorectal neoplasms; longitudinal analysis; pan-immune inflammation value; prognostic nutritional index; systemic immune-inflammation index

Share and Cite

MDPI and ACS Style

Herold, Z.; Herold, M.; Szentmartoni, G.; Szalasy, R.; Lohinszky, J.; Somogyi, A.; Szasz, A.M.; Dank, M. Are Calculated Immune Markers with or Without Comorbidities Good Predictors of Colorectal Cancer Survival? The Results of a Longitudinal Study. Med. Sci. 2025, 13, 108. https://doi.org/10.3390/medsci13030108

AMA Style

Herold Z, Herold M, Szentmartoni G, Szalasy R, Lohinszky J, Somogyi A, Szasz AM, Dank M. Are Calculated Immune Markers with or Without Comorbidities Good Predictors of Colorectal Cancer Survival? The Results of a Longitudinal Study. Medical Sciences. 2025; 13(3):108. https://doi.org/10.3390/medsci13030108

Chicago/Turabian Style

Herold, Zoltan, Magdolna Herold, Gyongyver Szentmartoni, Reka Szalasy, Julia Lohinszky, Aniko Somogyi, Attila Marcell Szasz, and Magdolna Dank. 2025. "Are Calculated Immune Markers with or Without Comorbidities Good Predictors of Colorectal Cancer Survival? The Results of a Longitudinal Study" Medical Sciences 13, no. 3: 108. https://doi.org/10.3390/medsci13030108

APA Style

Herold, Z., Herold, M., Szentmartoni, G., Szalasy, R., Lohinszky, J., Somogyi, A., Szasz, A. M., & Dank, M. (2025). Are Calculated Immune Markers with or Without Comorbidities Good Predictors of Colorectal Cancer Survival? The Results of a Longitudinal Study. Medical Sciences, 13(3), 108. https://doi.org/10.3390/medsci13030108

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop